Search Results - David Creytens
- Showing 1 - 2 results of 2
-
1
An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma by Astrid De Meulenaere, Tijl Vermassen, David Creytens, Stijn De Keukeleire, Tim Delahaye, Philippe Deron, Fréderic Duprez, Samson Fung, Patrick Pauwels, Liesbeth Ferdinande, Sylvie Rottey
Published 2021Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Validation of whole-slide digitally imaged melanocytic lesions: Does z-stack scanning improve diagnostic accuracy? by Bart Sturm, David Creytens, Martin G Cook, Jan Smits, Marcory C. R. F. van Dijk, Erik Eijken, Eline Kurpershoek, Heidi V. N Küsters-Vandevelde, Ariadne H. A. G. Ooms, Carla Wauters, Willeke A. M. Blokx, Jeroen A. W. M. van der Laak
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book